FDA-Inspected Site

Organon Pharma (UK) Ltd.

6 FDA inspections are on record for Organon Pharma (UK) Ltd. in Cramlington, United Kingdom.

483· Form 483 issued

Cramlington, United Kingdom · Last updated July 10, 2026

Overview

  • 6 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-06-13.

At a glance

Inspections

6

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Jun 2025 – 13 Jun 2025Human Drugs483View 483 →
12 Jun 2018 – 14 Jun 2018Human DrugsClean
2 Feb 2015 – 6 Feb 2015Human DrugsClean
18 Mar 2013 – 22 Mar 2013Human Drugs483View 483 →
9 Mar 2010Not recordedClean
16 May 2000Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

13 Jun 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Khoa Nathan V Tran

13 Jun 2025
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Khoa Nathan V Tran

13 Jun 2025
21 CFR 211.84(d)(2)

Component written specification

Cited by Khoa Nathan V Tran

22 Mar 2013
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Nicholas L Paulin

Investigators

FDA investigators tied to this site in the record.

MRA DavisM1 insp.
Bruce H Mccullough1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Organon Pharma (UK) Ltd.'s 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat